» Authors » Valerie Rhenius

Valerie Rhenius

Explore the profile of Valerie Rhenius including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 2345
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Davidson A, Michailidou K, Parsons M, Fortuno C, Bolla M, Wang Q, et al.
Am J Hum Genet . 2024 Aug; 111(9):2059-2069. PMID: 39096911
Co-observation of a gene variant with a pathogenic variant in another gene that explains the disease presentation has been designated as evidence against pathogenicity for commonly used variant classification guidelines....
2.
Wichert K, Hoppe R, Ickstadt K, Behrens T, Winter S, Herold R, et al.
Eur J Epidemiol . 2023 Oct; 38(10):1053-1068. PMID: 37789226
Light-at-night triggers the decline of pineal gland melatonin biosynthesis and secretion and is an IARC-classified probable breast-cancer risk factor. We applied a large-scale molecular epidemiology approach to shed light on...
3.
Middha P, Wang X, Behrens S, Bolla M, Wang Q, Dennis J, et al.
Breast Cancer Res . 2023 Aug; 25(1):93. PMID: 37559094
Background: Genome-wide studies of gene-environment interactions (G×E) may identify variants associated with disease risk in conjunction with lifestyle/environmental exposures. We conducted a genome-wide G×E analysis of ~ 7.6 million common...
4.
Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, et al.
J Med Genet . 2023 Jul; 60(12):1186-1197. PMID: 37451831
Background: Polygenic risk score (PRS), calculated based on genome-wide association studies (GWASs), can improve breast cancer (BC) risk assessment. To date, most BC GWASs have been performed in individuals of...
5.
Figlioli G, Billaud A, Wang Q, Bolla M, Dennis J, Lush M, et al.
Cancers (Basel) . 2023 Jul; 15(13). PMID: 37444426
germline protein truncating variants (PTVs) are moderate-risk factors for ER-negative breast cancer. We previously described the spectrum of PTVs in 114 European breast cancer cases. In the present, larger cohort,...
6.
Morra A, Schreurs M, Andrulis I, Anton-Culver H, Augustinsson A, Beckmann M, et al.
Cancer Med . 2023 Jul; 12(15):16142-16162. PMID: 37401034
Background: Breast cancer (BC) patients with a germline CHEK2 c.1100delC variant have an increased risk of contralateral BC (CBC) and worse BC-specific survival (BCSS) compared to non-carriers. Aim: To assessed...
7.
Morra A, Mavaddat N, Muranen T, Ahearn T, Allen J, Andrulis I, et al.
Am J Hum Genet . 2023 Feb; 110(3):475-486. PMID: 36827971
Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral breast cancer (CBC) risk and breast cancer-specific survival (BCSS) is scarce. The...
8.
Morra A, Schreurs M, Andrulis I, Anton-Culver H, Augustinsson A, Beckmann M, et al.
Res Sq . 2023 Feb; PMID: 36824750
Breast cancer (BC) patients with a germline c.1100delC variant have an increased risk of contralateral BC (CBC) and worse BC-specific survival (BCSS) compared to non-carriers. We aimed to assess the...
9.
Figlioli G, Billaud A, Ahearn T, Antonenkova N, Becher H, Beckmann M, et al.
Eur J Hum Genet . 2023 Jan; 31(5):578-587. PMID: 36707629
Evidence from literature, including the BRIDGES study, indicates that germline protein truncating variants (PTVs) in FANCM confer moderately increased risk of ER-negative and triple-negative breast cancer (TNBC), especially for women...
10.
Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn T, et al.
Breast Cancer Res . 2021 Aug; 23(1):86. PMID: 34407845
Background: Given the high heterogeneity among breast tumors, associations between common germline genetic variants and survival that may exist within specific subgroups could go undetected in an unstratified set of...